NASDAQ:PACB
Pacific Biosciences of California Stock News
$1.87
-0.0700 (-3.61%)
At Close: May 24, 2024
PacBio (PACB) Gets New Order for Revio System From Bioscientia
10:43am, Friday, 30'th Jun 2023
PacBio (PACB) receives new order for its Revio system from Bioscientia that will boost the latter's services. Here's how Revio can help Bioscientia improve diagnosis and treatment for monogenic disord
PacBio's (PACB) New Tie-Up to Boost Rare Disease Research
01:16pm, Tuesday, 20'th Jun 2023
PacBio's (PACB) latest collaboration is expected to highlight the feasibility and cost-effectiveness of using its HiFi sequencing technology.
Here's Why You Should Retain PacBio (PACB) Stock for Now
01:09pm, Friday, 02'nd Jun 2023
PacBio's (PACB) product development activities raise optimism about the stock.
PacBio (PACB) Tops on Q1 Earnings, Raises FY23 Revenue View
12:55pm, Wednesday, 03'rd May 2023
PacBio (PACB) witnesses strong revenue growth in the first quarter. This is partly aided by customers' product transition to the Revio system.
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates
06:23pm, Tuesday, 02'nd May 2023
Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.37 per share a year ago.
Assessing Pacific Biosciences And Their Revio Launch
06:34pm, Friday, 21'st Apr 2023
Assessing Pacific Biosciences And Their Revio Launch.
All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy
01:02pm, Tuesday, 11'th Apr 2023
Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PacBio's (PACB) New Offering to Enable High-Throughput Workflows
12:16pm, Tuesday, 11'th Apr 2023
PacBio's (PACB) latest launch is expected to combine the power of HiFi sequencing and Nanobind technology to optimize sample preparation workflows for its high-volume customers.
3 Reasons to Retain PacBio (PACB) Stock in Your Portfolio
01:41pm, Monday, 03'rd Apr 2023
PacBio's (PACB) product development activities raise optimism about the stock.
Pacific Biosciences (PACB) Stock Jumps 18.7%: Will It Continue to Soar?
10:39am, Monday, 03'rd Apr 2023
Pacific Biosciences (PACB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price in
Biotech stock Pacific Biosciences could return 50% in 12 months: TD Cowen
01:52pm, Friday, 31'st Mar 2023
Pacific Biosciences of California Inc (NASDAQ: PACB) is trading meaningfully up on Friday after a TD Cowen analyst turned super bullish on the biotechnology company. Pacific Biosciences stock has upsi
PacBio (PACB) New Revio Workflows to Boost Agricultural Output
03:11pm, Thursday, 30'th Mar 2023
PacBio (PACB), in collaboration with Corteva Agriscience, is likely to enable groundbreaking plant and microbial long-read sequencing workflow on Revio system.
Does Pacific Biosciences (PACB) Have the Potential to Rally 30.15% as Wall Street Analysts Expect?
11:29am, Tuesday, 28'th Mar 2023
The mean of analysts' price targets for Pacific Biosciences (PACB) points to a 30.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement am
PacBio's (PACB) Latest Offering to Enhance Genome Analysis
12:14pm, Wednesday, 15'th Mar 2023
PacBio's (PACB) new informatics analysis method, Paraphase, will enable researchers to genotype gene paralogs and pseudogenes with high accuracy.
PacBio (PACB) Q4 Earnings Match Estimates, Revenues Top
12:48pm, Friday, 17'th Feb 2023
Despite robust Consumables revenues, PacBio (PACB) witnesses overall soft performance in the fourth quarter.
